May 25, 2020
OFEV® (nintedanib) now available in Canada for adults living with progressive fibrosing interstitial lung diseases (PF-ILD)(1)
May 18, 2020
Wize Pharma's Strategic Transaction Partner Bonus BioGroup Reports Successful Treatment of Acute Pneumonia in Preclinical COVID-19 Model
Apr 06, 2020
Pulmonary Fibrosis Foundation Statement on COVID-19
Mar 26, 2020
COVID-19: What Those with Lung Disease Should Know
Mar 16, 2020
Insmed Provides Business Update
Mar 09, 2020
FDA approves Ofev® as first treatment for chronic fibrosing ILDs with a progressive phenotype
Feb 12, 2020
Bronchitis Treatment Market to Reach US$ 4.7 Bn by 2026, High Prevalence of Air Pollution Drives Growth: Transparency Market Research
Jan 29, 2020
MediPines a Featured Innovator at Emerging Medtech Summit 2020
Dec 02, 2019
CSA Medical, Inc. Announces European Approval for its RejuvenAir® System for COPD Patients with Chronic Bronchitis
Nov 07, 2019
New analysis of patients with autoimmune-related ILDs in the INBUILD study shown as poster presentation at the 2019 ACR/ARP Annual Meeting
Sep 26, 2019
New Clinical Results from RheOx(TM) System for Chronic Bronchitis to be Presented at European Respiratory Society (ERS) International Congress
Sep 04, 2019
Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis
May 09, 2019
Altavant Sciences to Provide Corporate and Clinical Update at 2019 Respiratory Innovation Summit
Jan 17, 2019
Gala Enrolls First Subject at Temple Lung Center as Part of the US Early Feasibility Trial of RheOx(TM) for Chronic Bronchitis in the United States
Jan 16, 2019
InventHelp Inventor Develops Tracheotomy Suction Device (SDB-1323)
Dec 12, 2018
Lower-priced spacer chambers could compromise young asthma patients' treatment
Nov 05, 2018
Gala Enrolls First Subjects in an Early Feasibility Study of RheOx(TM) for Chronic Bronchitis in the United States
Sep 18, 2018
RejuvenAir® Metered Cryospray(TM) Shows Promise as Treatment for COPD Patients with Chronic Bronchitis
Sep 17, 2018
Pulmatrix to present pre-clinical data on PUR1800 (RV1162) at the European Respiratory Society International Congress
Sep 17, 2018
Roivant Launches Respivant Sciences to Develop Innovative Therapeutics for Respiratory Diseases